Soldan S, Messick T, Lieberman P
Curr Opin Virol. 2022; 56:101260.
PMID: 36174496
PMC: 11058316.
DOI: 10.1016/j.coviro.2022.101260.
Huang Y, Liang J, Hu W, Liang Y, Xiao X, Zhao W
Front Microbiol. 2022; 13:919496.
PMID: 35847074
PMC: 9281874.
DOI: 10.3389/fmicb.2022.919496.
Munz C
Front Microbiol. 2021; 12:657387.
PMID: 34234755
PMC: 8257079.
DOI: 10.3389/fmicb.2021.657387.
Buschle A, Hammerschmidt W
Semin Immunopathol. 2020; 42(2):131-142.
PMID: 32232535
PMC: 7174264.
DOI: 10.1007/s00281-020-00792-2.
Li X, Kozlov S, El-Guindy A, Bhaduri-McIntosh S
J Virol. 2019; 93(17).
PMID: 31189703
PMC: 6694827.
DOI: 10.1128/JVI.00572-19.
Viral-Targeted Strategies Against EBV-Associated Lymphoproliferative Diseases.
Hui K, Yiu S, Tam K, Chiang A
Front Oncol. 2019; 9:81.
PMID: 30873380
PMC: 6400835.
DOI: 10.3389/fonc.2019.00081.
Immunodeficiencies that predispose to pathologies by human oncogenic γ-herpesviruses.
Damania B, Munz C
FEMS Microbiol Rev. 2019; 43(2):181-192.
PMID: 30649299
PMC: 6435449.
DOI: 10.1093/femsre/fuy044.
A cancer-associated Epstein-Barr virus BZLF1 promoter variant enhances lytic infection.
Bristol J, Djavadian R, Albright E, Coleman C, Ohashi M, Hayes M
PLoS Pathog. 2018; 14(7):e1007179.
PMID: 30052684
PMC: 6082571.
DOI: 10.1371/journal.ppat.1007179.
Short Chain Fatty Acids (SCFA) Reprogram Gene Expression in Human Malignant Epithelial and Lymphoid Cells.
Astakhova L, Ngara M, Babich O, Prosekov A, Asyakina L, Dyshlyuk L
PLoS One. 2016; 11(7):e0154102.
PMID: 27441625
PMC: 4956219.
DOI: 10.1371/journal.pone.0154102.
Flock house virus RNA polymerase initiates RNA synthesis de novo and possesses a terminal nucleotidyl transferase activity.
Wu W, Wang Z, Xia H, Liu Y, Qiu Y, Liu Y
PLoS One. 2014; 9(1):e86876.
PMID: 24466277
PMC: 3900681.
DOI: 10.1371/journal.pone.0086876.
Characterization of a nodavirus replicase revealed a de novo initiation mechanism of RNA synthesis and terminal nucleotidyltransferase activity.
Wang Z, Qiu Y, Liu Y, Qi N, Si J, Xia X
J Biol Chem. 2013; 288(43):30785-801.
PMID: 24019510
PMC: 3829395.
DOI: 10.1074/jbc.M113.492728.
BZLF1 governs CpG-methylated chromatin of Epstein-Barr Virus reversing epigenetic repression.
Woellmer A, Arteaga-Salas J, Hammerschmidt W
PLoS Pathog. 2012; 8(9):e1002902.
PMID: 22969425
PMC: 3435241.
DOI: 10.1371/journal.ppat.1002902.
Epigenetic histone modification of Epstein-Barr virus BZLF1 promoter during latency and reactivation in Raji cells.
Murata T, Kondo Y, Sugimoto A, Kawashima D, Saito S, Isomura H
J Virol. 2012; 86(9):4752-61.
PMID: 22357272
PMC: 3347330.
DOI: 10.1128/JVI.06768-11.
The B-cell specific transcription factor, Oct-2, promotes Epstein-Barr virus latency by inhibiting the viral immediate-early protein, BZLF1.
Robinson A, Kwek S, Kenney S
PLoS Pathog. 2012; 8(2):e1002516.
PMID: 22346751
PMC: 3276558.
DOI: 10.1371/journal.ppat.1002516.
Initiation of Epstein-Barr virus lytic replication requires transcription and the formation of a stable RNA-DNA hybrid molecule at OriLyt.
Rennekamp A, Lieberman P
J Virol. 2010; 85(6):2837-50.
PMID: 21191028
PMC: 3067963.
DOI: 10.1128/JVI.02175-10.
Either ZEB1 or ZEB2/SIP1 can play a central role in regulating the Epstein-Barr virus latent-lytic switch in a cell-type-specific manner.
Ellis A, Wang Z, Yu X, Mertz J
J Virol. 2010; 84(12):6139-52.
PMID: 20375168
PMC: 2876653.
DOI: 10.1128/JVI.02706-09.
Epstein-barr virus latency in B cells leads to epigenetic repression and CpG methylation of the tumour suppressor gene Bim.
Paschos K, Smith P, Anderton E, Middeldorp J, White R, Allday M
PLoS Pathog. 2009; 5(6):e1000492.
PMID: 19557159
PMC: 2695769.
DOI: 10.1371/journal.ppat.1000492.
ZEB1 regulates the latent-lytic switch in infection by Epstein-Barr virus.
Yu X, Wang Z, Mertz J
PLoS Pathog. 2007; 3(12):e194.
PMID: 18085824
PMC: 2134958.
DOI: 10.1371/journal.ppat.0030194.
De novo protein synthesis is required for lytic cycle reactivation of Epstein-Barr virus, but not Kaposi's sarcoma-associated herpesvirus, in response to histone deacetylase inhibitors and protein kinase C agonists.
Ye J, Gradoville L, Daigle D, Miller G
J Virol. 2007; 81(17):9279-91.
PMID: 17596302
PMC: 1951462.
DOI: 10.1128/JVI.00982-07.
Virus and cell RNAs expressed during Epstein-Barr virus replication.
Yuan J, Cahir-McFarland E, Zhao B, Kieff E
J Virol. 2006; 80(5):2548-65.
PMID: 16474161
PMC: 1395376.
DOI: 10.1128/JVI.80.5.2548-2565.2006.